New data from wastewater analysis by the Swiss Federal Institute of Aquatic Science and Technology (Eawag) points to a notable rise in ketamine consumption. The research, which offers a snapshot of drug use patterns, suggests an emerging public health trend across the country.

"Wastewater analysis cannot identify individual users, but it offers a broad barometer of changing habits."
"For ketamine, at least, the direction of travel is clear."
The sewers of Switzerland are telling a new, unsettling story: Ketamine consumption is soaring. New data released for the first half of 2025 by Dromedario, a substance-monitoring portal, reveals a marked and undeniable increase in traces of the dissociative anesthetic flowing through the country's wastewater systems. This is not a statistical anomaly; it is a clear signal of shifting drug habits across the confederation.
Researchers at the Swiss Federal Institute of Aquatic Science and Technology (Eawag) have turned the country's water treatment plants into massive diagnostic tools. By analyzing sewage samples, they have bypassed self-reported surveys to uncover the raw reality of Swiss consumption. While Ketamine remains a critical medical anesthetic, the sheer volume detected suggests the drug has migrated from the operating theatre to the dance floor. The data offers an unvarnished snapshot of a public health trend that is rapidly gaining momentum, forcing health officials to confront a rising tide of "Special K" usage.
Zurich is the epicenter of this chemical surge. The data is unequivocal: ketamine concentrations in Switzerland's largest city significantly exceed the average recorded across ten other Swiss monitoring sites. But it is the timing of these detections that reveals the true nature of the consumption. The levels do not remain flat; they spike dramatically on weekends.
This temporal pattern is the smoking gun for recreational use. While medical applications of ketamine would produce a steady baseline, the weekend surges point directly to the club scene and nightlife economy. In these settings, the drug—colloquially known as "K" or "Ket"—is being consumed at rates that dwarf previous years. The distinction between a patient in surgery and a partygoer in Zurich is now chemically visible in the city's infrastructure. The weekend gap offers a critical clue that illicit consumption is driving these numbers to record heights.
Ketamine is not the only substance flashing red on the dashboard. A parallel and equally alarming trend is visible for crack cocaine. Researchers tracking AEME—the specific chemical marker produced when crack is smoked—have documented a noticeable rise in levels throughout 2025. This is not isolated to the major metropolises; it is a spreading phenomenon.
Zurich again leads the statistics, but the city of Chur has also registered pronounced peaks, particularly on weekends. This correlation suggests a broader intensification of stimulant use alongside dissociatives. The weekend-heavy usage patterns for both substances paint a picture of high-intensity recreational consumption that is pushing the limits of public health resources. While the substances differ in effect, the trajectory is identical: upward, urgent, and concentrated in urban hubs.
In a surprising twist, not all drug indicators are pointing skyward. While Ketamine and crack cocaine surge, other staples of the illicit market appear to be losing their grip. Methamphetamine, commonly known as crystal meth, has seen a slight but steady decline nationwide since monitoring protocols began in 2021. The market for this stimulant appears to be contracting, or at least stabilizing, in stark contrast to the volatility seen elsewhere.
Even Cannabis, long a staple of recreational drug use, is showing signs of a downturn. Concentrations of THC-COOH, the breakdown product detectable in urine, were measurably lower in the first two quarters of 2025 compared to previous years. This data suggests a potential substitution effect, where users may be migrating from traditional substances like cannabis and meth toward the more potent, dissociative highs of ketamine. The landscape of Swiss drug culture is not just growing; it is evolving.
The rise in "K" is not merely a statistical curiosity; it carries severe physical consequences. Frequent use is inextricably linked to cognitive impairment and dependence, but the most visceral danger is "ketamine bladder." This condition causes severe, irreversible damage to the bladder lining, leading to excruciating pain and urinary dysfunction. In the most critical cases, the damage is so extensive that surgical removal of the bladder is the only option.
As consumption levels in Zurich and beyond reach new highs, the Swiss healthcare system must brace for the fallout. The wastewater data serves as an early warning system, predicting a future wave of complex medical cases. While the sewers cannot identify individual users, the aggregate data is a loud siren for public health officials. The direction of travel is clear, and without intervention, the cost will be measured not just in micrograms per liter, but in life-altering surgeries and long-term addiction battles.